G1 Therapeutics and Pepper Bio Ink Global License Agreement for Lerociclib
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics…
Source: hitconsultant.net
Stay updated with breaking news from Merck Digital Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics…
“The Voice of New Jersey Tech."